Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approval
Biotech
Outlook lays off 23% of staff as it eyes FDA approval, EU debut
The move, which came after an internal strategic review, is meant to streamline operations and save the company $1.4 million annually.
Darren Incorvaia
Dec 16, 2024 8:25am
FDA approves Abbott dissolving stent for arteries below the knee
Apr 29, 2024 9:54am
Medtronic nets FDA approval for evolved Evolut TAVR valve
Mar 27, 2024 10:06am
Edwards excites with Evoque transcath tricuspid valve FDA nod
Feb 2, 2024 9:43am
Boston Scientific's Farapulse system nets FDA approval in afib
Jan 31, 2024 11:01am
FDA approves Abbott’s smallest, longest-lasting DBS implant
Jan 25, 2024 11:57am
